|
Effect of MM-141 on gemcitabine and nab-paclitaxel potentiation in preclinical models of pancreatic cancer through induction of IGF-1R and ErbB3 degradation. |
|
|
Employment - Merrimack; Merrimack (I) |
Stock and Other Ownership Interests - Merrimack; Merrimack (I) |
Consulting or Advisory Role - Merrimack (I) |
Travel, Accommodations, Expenses - Merrimack; Merrimack (I) |
|
|
|
Stock and Other Ownership Interests - Merrimack |
Research Funding - Merrimack |
Travel, Accommodations, Expenses - Merrimack |
|
|
|
Stock and Other Ownership Interests - Merrimack |
Travel, Accommodations, Expenses - Merrimack |
|
|
|
Stock and Other Ownership Interests - Acorda Therapeutics; Alnylam (I); Merrimack; Organovo; Tekmira |
Patents, Royalties, Other Intellectual Property - Merrimack (Inst) |
Travel, Accommodations, Expenses - Merrimack |
|
|
|
Stock and Other Ownership Interests - Merrimack |
Travel, Accommodations, Expenses - Merrimack |
|
|
|
Stock and Other Ownership Interests - Merrimack |
Travel, Accommodations, Expenses - Merrimack |
|
|
|
Stock and Other Ownership Interests - Merrimack |
Travel, Accommodations, Expenses - Merrimack |
|
|
|
Stock and Other Ownership Interests - Merrimack |
Travel, Accommodations, Expenses - Merrimack |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - Merrimack |
Travel, Accommodations, Expenses - Merrimack |
|
|
|
Stock and Other Ownership Interests - Merrimack |
Patents, Royalties, Other Intellectual Property - Biogen; Merrimack |
Travel, Accommodations, Expenses - Oxford Global |